131 related articles for article (PubMed ID: 8582456)
21. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
Heeren J; Niemeier A; Merkel M; Beisiegel U
J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.
Gianturco SH; Ramprasad MP; Song R; Li R; Brown ML; Bradley WA
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):968-76. PubMed ID: 9633939
[TBL] [Abstract][Full Text] [Related]
23. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
[TBL] [Abstract][Full Text] [Related]
24. Effect of lipoprotein lipase on binding of chylomicrons to LDL receptor-deficient Chinese hamster ovary cells.
Kobayashi J; Tashiro J; Bujo H; Morisaki N; Saito Y
Ann Clin Biochem; 2001 Mar; 38(Pt 2):124-8. PubMed ID: 11269752
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix.
Saxena U; Auerbach BJ; Ferguson E; Wölle J; Marcel YL; Weisgraber KH; Hegele RA; Bisgaier CL
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1240-7. PubMed ID: 7627718
[TBL] [Abstract][Full Text] [Related]
26. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix.
Saxena U; Ferguson E; Bisgaier CL
J Biol Chem; 1993 Jul; 268(20):14812-9. PubMed ID: 8325860
[TBL] [Abstract][Full Text] [Related]
28. Receptor-mediated mechanisms of lipoprotein remnant catabolism.
Chappell DA; Medh JD
Prog Lipid Res; 1998 Dec; 37(6):393-422. PubMed ID: 10209655
[TBL] [Abstract][Full Text] [Related]
29. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
[TBL] [Abstract][Full Text] [Related]
30. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
[TBL] [Abstract][Full Text] [Related]
31. Chylomicrons and lipoprotein lipase at the endothelial surface: bound and GAG-ged?
Ory DS
Cell Metab; 2007 Apr; 5(4):229-31. PubMed ID: 17403366
[TBL] [Abstract][Full Text] [Related]
32. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
33. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone.
Niemeier A; Kassem M; Toedter K; Wendt D; Ruether W; Beisiegel U; Heeren J
J Bone Miner Res; 2005 Feb; 20(2):283-93. PubMed ID: 15647823
[TBL] [Abstract][Full Text] [Related]
34. Dual localization of lipoprotein lipase in rat heart. Its relationship to chylomicron degradation.
Stam H; Jansen H; Hülsmann WC
Adv Myocardiol; 1982; 3():509-17. PubMed ID: 7170439
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Williams KJ; Petrie KA; Brocia RW; Swenson TL
J Clin Invest; 1991 Oct; 88(4):1300-6. PubMed ID: 1918380
[TBL] [Abstract][Full Text] [Related]
36. The role of alpha 2M receptor/LRP in chylomicron remnant metabolism.
Beisiegel U; Krapp A; Weber W; Olivecrona G
Ann N Y Acad Sci; 1994 Sep; 737():53-69. PubMed ID: 7524435
[TBL] [Abstract][Full Text] [Related]
37. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
Choi SY; Fong LG; Kirven MJ; Cooper AD
J Clin Invest; 1991 Oct; 88(4):1173-81. PubMed ID: 1918372
[TBL] [Abstract][Full Text] [Related]
38. The uptake of chylomicron remnants by the liver.
Windler EE
Adv Exp Med Biol; 1987; 210():131-5. PubMed ID: 3591544
[No Abstract] [Full Text] [Related]
39. Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin.
Huettinger M; Retzek H; Hermann M; Goldenberg H
J Biol Chem; 1992 Sep; 267(26):18551-7. PubMed ID: 1382056
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein lipase-enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: secretion-capture process of apoE is a possible route for the catabolism of Lp(a).
van Barlingen HH; Kleinveld HA; Erkelens DW; de Bruin TW
Metabolism; 1997 Jun; 46(6):650-5. PubMed ID: 9186300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
